Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer telehealth. On Wednesday, the Federal Trade Commission sued direct-to-consumer telehealth company Hims & Hers, continuing a pattern of action against digital health companies’ business practices and use of consumer health data. The FTC, along with Utah and California, alleged that Hims deceived consumers in several ways when they purchased clinical care and medications through the site. The telehealth company misled consumers about sharing their sensitive health information with third parties including Meta and Snap, the suit claims. It also alleges that Hims isn’t clear that when consumers fill out a medical history, they are signing up for a subscription that continually renews and bills them for medication.